Herkenham, M. et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563–583 (1991).
Munro, S., Thomas, K. L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–65 (1993).
Battista, N., Tommaso, M. D., Bari, M. & Maccarrone, M. The endocannabinoid system: An overview. Front. Behav. Neurosci. 6, 9 (2012).
Mechoulam, R. & Parker, L. A. The endocannabinoid system and the brain. Ann. Rev. Psychol. 64, 21–47 (2013).
Lu, H.-C. & Mackie, K. An introduction to the endogenous cannabinoid system. Biol. Psychiatry 79, 516–525 (2016).
Zou, S. & Kumar, U. Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int. J. Mol. Sci. 19, 833 (2018).
Walsh, K. B. & Andersen, H. K. Molecular pharmacology of synthetic cannabinoids: Delineating CB1 receptor-mediated cell signaling. Int. J. Mol. Sci. 21, 6115 (2020).
Malfitano, A. M., Basu, S., Maresz, K., Bifulco, M. & Dittel, B. N. What we know and do not know about the cannabinoid receptor 2 (CB2). Semin. Immunol. 26, 369–379 (2014).
Hua, T. et al. Crystal structure of the human cannabinoid receptor CB1. Cell 167, 750–762.e14 (2016).
Shao, Z. et al. High-resolution crystal structure of the human CB1 cannabinoid receptor. Nature 540, 602–606 (2016).
Hua, T. et al. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547, 468–471 (2017).
Li, X. et al. Crystal structure of the human cannabinoid receptor CB2. Cell 176, 459–467.e13 (2019).
Kumar, K. K. et al. Structure of a signaling cannabinoid receptor 1-g protein complex. Cell 176, 448–458.e12 (2019).
Shao, Z. et al. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor. Nat. Chem. Biol. 15, 1199–1205 (2019).
Xing, C. et al. Cryo-EM structure of the human cannabinoid receptor CB2-gi signaling complex. Cell 180, 645–654.e13 (2020).
Hua, T. et al. Activation and signaling mechanism revealed by cannabinoid receptor-gi complex structures. Cell 180, 655–665.e18 (2020).
Wang, X. et al. A genetically encoded f-19 NMR probe reveals the allosteric modulation mechanism of cannabinoid receptor 1. J. American Chem. Soc. 143, 16320–16325 (2021).
Rosenbaum, D. M., Rasmussen, S. G. F. & Kobilka, B. K. The structure and function of g-protein-coupled receptors. Nature 459, 356–363 (2009).
Latorraca, N. R., Venkatakrishnan, A. J. & Dror, R. O. GPCR dynamics: Structures in motion. Chem. Rev. 117, 139–155 (2016).
Weis, W. I. & Kobilka, B. K. The molecular basis of g protein–coupled receptor activation. Ann. Rev. Biochem. 87, 897–919 (2018).
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: New agents, targets and indications. Nat. Rev. Drug Discov. 16, 829–842 (2017).
Odoemelam, C. S. et al. G-protein coupled receptors: Structure and function in drug discovery. RSC Adv. 10, 36337–36348 (2020).
Yang, D. et al. G protein-coupled receptors: Structure- and function-based drug discovery. Signal Transduc. Targeted Ther. 6, 7 (2021).
Pertwee, R. G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6, 635–664 (1999).
Howlett, A. C. International union of pharmacology. XXVII. classification of cannabinoid receptors. Pharmacol. Rev. 54, 161–202 (2002).
Pertwee, R. G. & Ross, R. Cannabinoid receptors and their ligands. Prostaglandins, Leukotrienes Essential Fatty Acids (PLEFA) 66, 101–121 (2002).
Pertwee, R. G. Cannabinoid pharmacology: The first 66 years. Brit. J. Pharmacol. 147, S163–S171 (2006).
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M. & Tracy, D. K. New psychoactive substances: A review and updates. Ther. Adv. Psychopharmacol. 10, 204512532096719 (2020).
Wiley, J. L., Marusich, J. A. & Huffman, J. W. Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids. Life Sci. 97, 55–63 (2014).
Davis, M. P. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Expert Opin. Investigational Drugs 23, 1123–1140 (2014).
Li, X., Shen, L., Hua, T. & Liu, Z.-J. Structural and functional insights into cannabinoid receptors. Trends Pharmacol. Sci. 41, 665–677 (2020).
Pertwee, R. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr. Med. Chem. 17, 1360–1381 (2010).
Rogers, N. Cannabinoid receptor with an ‘identity crisis’ gets a second look. Nat. Med. 21, 966–967 (2015).
Soethoudt, M. et al. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity. Nat. Commun. 8, 13958 (2017).
Li, X., Shen, L., Hua, T. & Liu, Z.-J. Structural and functional insights into cannabinoid receptors. Trends Pharmacol. Sci. 41, 665–677 (2020).
Magham, S. V., krishnamurthy, P. T., Shaji, N., Mani, L. & Balasubramanian, S. Cannabinoid receptor 2 selective agonists and alzheimers disease: An insight into the therapeutic potentials. J. Neurosci. Res. 99, 2888–2905 (2021).
Whiting, Z. M., Yin, J., de la Harpe, S. M., Vernall, A. J. & Grimsey, N. L. Developing the cannabinoid receptor 2 (CB2) pharmacopoeia: Past, present, and future. Trends Pharmacol. Sci. 43, 754–771 (2022).
Peng, Y. et al. 5-HT2c receptor structures reveal the structural basis of GPCR polypharmacology. Cell 172, 719–730.e14 (2018).
Katritch, V., Kufareva, I. & Abagyan, R. Structure based prediction of subtype-selectivity for adenosine receptor antagonists. Neuropharmacology 60, 108–115 (2011).
Ostopovici-Halip, L., Curpăn, R., Mracec, M. & Bologa, C. G. Structural determinants of the alpha2 adrenoceptor subtype selectivity. J. Mol. Graphics Modelling 29, 1030–1038 (2011).
Sallander, J., Wallinder, C., Hallberg, A., Åqvist, J. & de Terán, H. G. Structural determinants of subtype selectivity and functional activity of angiotensin II receptors. Bioorganic Med. Chem. Lett. 26, 1355–1359 (2016).
Rataj, K. et al. Fingerprint-based machine learning approach to identify potent and selective 5-HT2br ligands. Molecules 23, 1137 (2018).
Ma, C., Wang, L. & Xie, X.-Q. Ligand classifier of adaptively boosting ensemble decision stumps (LiCABEDS) and its application on modeling ligand functionality for 5ht-subtype GPCR families. J. Chem. Inform. Modeling 51, 521–531 (2011).
Rodríguez, D., Brea, J., Loza, M. I. & Carlsson, J. Structure-based discovery of selective serotonin 5-HT 1b receptor ligands. Structure 22, 1140–1151 (2014).
Glukhova, A. et al. Structure of the adenosine a1 receptor reveals the basis for subtype selectivity. Cell 168, 867–877.e13 (2017).
Ma, C., Wang, L., Yang, P., Myint, K. Z. & Xie, X.-Q. LiCABEDS II. modeling of ligand selectivity for g-protein-coupled cannabinoid receptors. J. Chem. Inform. Modeling 53, 11–26 (2013).
Hu, B. et al. Three-dimensional biologically relevant spectrum (BRS-3d): Shape similarity profile based on PDB ligands as molecular descriptors. Molecules 21, 1554 (2016).
Mardt, A., Pasquali, L., Wu, H. & Noé, F. VAMPnets for deep learning of molecular kinetics. Nat. Commun. 9, 5 (2018).
Fleetwood, O., Carlsson, J. & Delemotte, L. Identification of ligand-specific g protein-coupled receptor states and prediction of downstream efficacy via data-driven modeling. eLife 10, e60715 (2021).
Maharana, J., Banerjee, R., Yadav, M. K., Sarma, P. & Shukla, A. K. Emerging structural insights into GPCR–β-arrestin interaction and functional outcomes. Curr. Opin. Struc. Biol. 75, 102406 (2022).
Bhattacharya, S. & Vaidehi, N. Differences in allosteric communication pipelines in the inactive and active states of a gpcr. Biophys. J. 107, 422–434 (2014).
Paul, F. & Weikl, T. R. How to distinguish conformational selection and induced fit based on chemical relaxation rates. PLOS Comput. Biol. 12, e1005067 (2016).
Case, D. et al. AMBER 2018. University of California, San Francisco.https://ambermd.org/doc12/Amber18.pdf (2020).
Mark, P. & Nilsson, L. Structure and dynamics of the TIP3p, SPC, and SPC/e water models at 298 k. J. Phys. Chem. A 105, 9954–9960 (2001).
Li, Y., Sun, J., Li, D. & Lin, J. The full activation mechanism of the adenosine a1 receptor revealed by gamd and su-gamd simulations. Proc. Natl. Acad. Sci. 119, e2203702119 (2022).
Ding, T., Karlov, D. S., Pino-Angeles, A. & Tikhonova, I. G. Intermolecular interactions in g protein-coupled receptor allosteric sites at the membrane interface from molecular dynamics simulations and quantum chemical calculations. J. Chem. Inform. Modeling 62, 4736–4747 (2022).
Li, Y., Yin, C., Liu, P., Li, D. & Lin, J. Identification of a different agonist-binding site and activation mechanism of the human p2y1 receptor. Scientific Rep. 7, 13764 (2017).
Maier, J. A. et al. ff14sb: improving the accuracy of protein side chain and backbone parameters from ff99sb. J. Chem. Theory Comput. 11, 3696–3713 (2015).
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Computat. Chem. 25, 1157–1174 (2004).
Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graphics Modelling 25, 247–260 (2006).
Jo, S., Kim, T., Iyer, V. G. & Im, W. Charmm-gui: a web-based graphical user interface for charmm. J. Comput. Chem. 29, 1859–1865 (2008).
Salomon-Ferrer, R., Götz, A. W., Poole, D., Grand, S. L. & Walker, R. C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. explicit solvent particle mesh ewald. J. Chem. Theory Comput. 9, 3878–3888 (2013).
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684–3690 (1984).
Krautler, V., van Gunsteren, W. F. & Hunenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501–508 (2001).
Essmann, U. et al. A smooth particle mesh ewald method. J. Chem. Phys. 103, 8577–8593 (1995).
Zhou, Q. et al. Common activation mechanism of class a GPCRs. eLife 8, 50279 (2019).
Bansal, P. D., Dutta, S. & Shukla, D. Activation mechanism of the human smoothened receptor. Biophys. J. 122, 1400–1413 (2023).
Kohlhoff, K. J. et al. Cloud-based simulations on google exacycle reveal ligand modulation of GPCR activation pathways. Nat. Chem. 6, 15–21 (2013).
Dror, R. O. et al. Activation mechanism of the β 2-adrenergic receptor. Proc. Natl. Acad. Sci. 108, 18684–18689 (2011).
Vilardaga, J.-P. Theme and variations on kinetics of GPCR activation/deactivation. J. Recep. Signal Transduc. 30, 304–312 (2010).
Braun, E. et al. Best practices for foundations in molecular simulations [article v1.0]. Living J. Comput. Molecular Sci. 1, 5957 (2019).
Zimmerman, M. I., Porter, J. R., Sun, X., Silva, R. R. & Bowman, G. R. Choice of adaptive sampling strategy impacts state discovery, transition probabilities, and the apparent mechanism of conformational changes. J. Chem. Theory Comput. 14, 5459–5475 (2018).
Bowman, G. R., Ensign, D. L. & Pande, V. S. Enhanced modeling via network theory: Adaptive sampling of markov state models. J. Chem. Theory Comput. 6, 787–794 (2010).
Kleiman, D. E. & Shukla, D. Multiagent reinforcement learning-based adaptive sampling for conformational dynamics of proteins. J. Chem. Theory Comput. 18, 5422–5434 (2022).
Shamsi, Z., Cheng, K. J. & Shukla, D. Reinforcement learning based adaptive sampling: REAPing rewards by exploring protein conformational landscapes. J. Phys. Chem. B 122, 8386–8395 (2018).
Dutta, S., Selvam, B., Das, A. & Shukla, D. Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors. J. Biol. Chem. 298, 101764 (2022).
Shukla, S., Zhao, C. & Shukla, D. Dewetting controls plant hormone perception and initiation of drought resistance signaling. Structure 27, 692–702.e3 (2019).
Buch, I., Giorgino, T. & Fabritiis, G. D. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations. Proc. Natl. Acad. Sci. 108, 10184–10189 (2011).
Betz, R. M. & Dror, R. O. How effectively can adaptive sampling methods capture spontaneous ligand binding? J. Chem. Theory Comput. 15, 2053–2063 (2019).
Doerr, S. & De Fabritiis, G. On-the-fly learning and sampling of ligand binding by high-throughput molecular simulations. J. Chem. Theory Comput. 10, 2064–2069 (2014).
Dutta, S., Selvam, B. & Shukla, D. Distinct binding mechanisms for allosteric sodium ion in cannabinoid receptors. ACS Chem. Neurosci. 13, 379–389 (2022).
Pereira, G. V. et al. Degradation of complex arabinoxylans by human colonic bacteroidetes. Nat. Commun. 12, 459 (2021).
Husic, B. E. & Pande, V. S. Markov state models: From an art to a science. J. American Chem. Soc. 140, 2386–2396 (2018).
Konovalov, K. A., Unarta, I. C., Cao, S., Goonetilleke, E. C. & Huang, X. Markov state models to study the functional dynamics of proteins in the wake of machine learning. JACS Au 1, 1330–1341 (2021).
Shukla, D., Hernández, C. X., Weber, J. K. & Pande, V. S. Markov state models provide insights into dynamic modulation of protein function. Acc. Chem. Res. 48, 414–422 (2015).
Prinz, J.-H. et al. Markov models of molecular kinetics: Generation and validation. J. Chem. Phys. 134, 174105 (2011).
Schwantes, C. R. & Pande, V. S. Improvements in markov state model construction reveal many non-native interactions in the folding of ntl9. J. Chem. Theory Comput. 9, 2000–2009 (2013).
Sultan, M. M., Kiss, G. & Pande, V. S. Towards simple kinetic models of functional dynamics for a kinase subfamily. Nat. Chem. 10, 903–909 (2018).
Noé, F. & Nuske, F. A variational approach to modeling slow processes in stochastic dynamical systems. Multiscale Modeling Simulation 11, 635–655 (2013).
McGibbon, R. T. & Pande, V. S. Variational cross-validation of slow dynamical modes in molecular kinetics. J. Chemical Phys. 142, 124105 (2015).
Noé, F., Tkatchenko, A., Müller, K.-R. & Clementi, C. Machine learning for molecular simulation. Ann. Rev. Phys. Chem. 71, 361–390 (2020).
Scherer, M. K. et al. Pyemma 2: A software package for estimation, validation, and analysis of markov models. J. Chem. Theory Comput. 11, 5525–5542 (2015).
McGibbon, R. T. et al. Mdtraj: A modern open library for the analysis of molecular dynamics trajectories. Biophys. J. 109, 1528 – 1532 (2015).
Humphrey, W., Dalke, A. & Schulten, K. Vmd: visual molecular dynamics. J. Mol. Graphics 14, 33–38 (1996).
Roe, D. R. & Cheatham III, T. E. Ptraj and cpptraj: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084–3095 (2013).
Wagner, J. R. et al. Povme 3.0: software for mapping binding pocket flexibility. J. Chem. Theory Comput. 13, 4584–4592 (2017).
Glielmo, A. et al. Unsupervised learning methods for molecular simulation data. Chem. Rev. 121, 9722–9758 (2021).
Hoffmann, M. et al. Deeptime: a python library for machine learning dynamical models from time series data. Machine Learning: Sci. Technol. 3, 015009 (2021).
Hernández, C. X. & Pande, V. S. MDEntropy: Information-theoretic analyses for molecular dynamics. J. Open Source Softw. 2, 427 (2017).
Kim, S. et al. PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Res. 49, D1388–D1395 (2020).
Trott, O. & Olson, A. J. AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2009).
Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings. J. Chem. Inform. Modeling 61, 3891–3898 (2021).
Noé, F., Schütte, C., Vanden-Eijnden, E., Reich, L. & Weikl, T. R. Constructing the equilibrium ensemble of folding pathways from short off-equilibrium simulations. Proc. Natl. Acad. Sci. 106, 19011–19016 (2009).
E, W. & Vanden-Eijnden, E. Transition-path theory and path-finding algorithms for the study of rare events. Ann. Rev. Phys. Chem. 61, 391–420 (2010).
Shukla, D., Meng, Y., Roux, B. & Pande, V. S. Activation pathway of src kinase reveals intermediate states as targets for drug design. Nat. Commun. 5, 3397 (2014).